期刊文献+

免疫性血小板减少性紫癜合并急性心肌梗死的临床特征及相关文献复习 被引量:8

A case report and related literature review about thecharacteristics of acute myocardial infarction combined with idiopathic thrombocytopenia purpura
下载PDF
导出
摘要 目的:探讨免疫性血小板减少性紫癜( immune thrombocytopenic purpura, ITP)合并急性心肌梗死( acute myocardial infarction, AMI)病例的临床特征、发病机制、预防及治疗方法。方法回顾性总结1例在ITP治疗过程中发生两次非ST段抬高性心肌梗死患者的临床特征,结合该例患者在该院的诊治经历并复习相关文献,总结分析其临床特征、发病机制、预防及治疗方法。结果迄今为止,文献报道ITP合并AMI患者共11例(包括本例)均为慢性型ITP患者,平均年龄62.64岁,男女比例为6∶5。其中9例合并一个或多个冠心病危险因素。结论 ITP患者发生AMI可能存在特殊机制,与内皮损伤及微循环障碍相关,也与ITP治疗过程相关。因此,对于合并多种冠心病危险因素的ITP患者,短时间快速升高血小板需谨慎。对于大面积STEMI无ITP所致出血征象,行急诊冠状动脉造影及术后抗血小板治疗是安全的。 Objective To investigate the clinical features, pathogenesis, prevention and treatment of acute myocardial infarction ( AMI ) combined with immune thrombocytopenic purpura ( ITP) .Methods We reported a case of an old man who suffered acute myocardial infarction twice during the treatment of ITP and reviewed data available in the literature and discussed the clinical characteristics, pathogenesis, prevention and treatment.Results Only 11 cases reports of AMI with ITP are available in the literature ( including this case) .All of ITPs were chronic with an average age of 62.64, Male/Female ratio was 6∶5.Among them, 9 patients had one or more risk factors for coronary heart disease.Conclusion TP patients with AMI may exist special mechanism: beside endothelial injury and microcirculation, we should considered the process of ITP treatment.However, careful attention must be paid for a rapid rise in the plateletcount, which may induce myocardial infarction or stroke, particularly in the elderly patients and in patients withcoronary risk factors.For patients with large area STEMI and no signs of bleeding caused by ITP, emergency coronary angiography and postoperative antiplatelet therapy are all safe.
出处 《中国急救医学》 CAS CSCD 北大核心 2015年第4期323-326,共4页 Chinese Journal of Critical Care Medicine
关键词 免疫性血小板减少性紫癜(ITP) 急性心肌梗死(AMI) 临床特征 Immune thrombocytopenic purpura (ITP) Acute myocardial infarction (AMI) Clinical characteristics
  • 相关文献

参考文献17

  • 1Fruchter O, Blich M, Jacob G. Fatal acute myocardial infarctionduring severe thrombocytopenia in a patient with idiopathic thrombocyto- penic purpura[ J]. Am J Med Sci, 2002, 323(5) : 279 -280.
  • 2Taylor SM, Reilly MP, Schreiber AD, et al. Thrombosis and shock induced by activating antiplatelet antibodies in human Fc gamma RIIA transgenic mice: the interplay among antibody, spleen, and Fc receptor [ J ]. Blood, 2000, 96 ( 13 ) : 4254 - 4260.
  • 3Koller A, Balasko M, Bagi Z. Endothelial regulation of coronary microcirculation in health and cardiometabolic diseases[ J]. Intern Emerg Med, 2013, 8(Suppl 1) : S51 -54.
  • 4Vallbracht KB, Schwimmbeck PL, Kohl U, et al. Differential as-pects of endothelial function of the coronary microcirculation con- sidering myocardial virus persistence, endothelial activation, and myocardial leukocyte infiltrates [ J ]. Circulation, 2005, 111 (14) : 1784 -1791.
  • 5Heit JA. Cardiovascular endocrinology: Risk of venous thrombocmbo- lism with glucocorticoids[ J]. Nat Rev Endocrinol, 2013, 9 (7) : 387 - 388.
  • 6Paolini R, Fabris F, Celia G. Acute myocardial infarction during treatment with intravenous immunoglobulin for idiopathic thrombo- cytopenic purpura( ITP ) [ J ]. Am J Hematol, 2000, 65 ( 2 ) : 177 - 178.
  • 7Elkayam O, Paran D, Milo R, et al. Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmnne disorders. A study of four cases [ J ]. Ann Rheum Dis, 2000, 59(1) : 77-80.
  • 8Reinhart WH, Berchtold PE. Effect of high - dose intravenous im- munoglobnlin therapy on blood theology[J]. Lancet, 1992, 339 (8794) : 662 - 664.
  • 9Yagmur J, Cansel M, Acikgoz N, et al. Multivessel coronary thrombosis in a patient with idiopathic thrombocytopenic purpura [J]. Tex Heart Inst J, 2012, 39(6) : 881 -883.
  • 10Yildiz A, Coskun U, Batukan OE, et al. Primary percutaneous coronary intervention for acute myocardial infarction in a young female with idiopathic thrombocytopenic purpura: a case report and review[J]. Case Rep Med, 2010, 2010: 854682.

二级参考文献20

  • 1Burns TR,Saleen A.Idiopathic thrombocytopenic purpura. AmJ Med, 1983,75:1001-7.
  • 2Jun-Hyung Kim,Keon-UK Park,Woo-Jung Chun,et al. Primary percutaneous coronary intervention for acute myocardial infarction with idiopathic thrombocytopenic purpura : A Case Report.J Korean Med Sci, 2006,21:355-57.
  • 3Toshikazu Fuchi,Takao Kondo,Kazuhiro Sase,et al. Primary percutaneous transluminal coronary angioplasty performed for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura.Jpn Circ J, 1999,63:133-136.
  • 4Fruchter D,Blich M,Jacob G.Fatal acute myocardial infarction during severe thromboeytopenia in a patient with idiopathic thrombocytopenic puroura.Am J Med Sci ,2002,323:279-80.
  • 5Mathew TC,Vasudevan R,Leb L,et al.Coronary artery bypass grafting in immune thrombocytopenic purpura.Ann Thorac Surg ,1997,64: 1059-1062.
  • 6Woodruff RK,Grigg AP, Firkin FC,et al.Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients.Lancet ,1986,2:217-218.
  • 7George IN, KoJouri K. Immune thrombocytopenic purpura//Craig Kitchens, Barbara Alving, Craig Kessler. Consultative homeostasis and thrombosis. 2rd ed. 2007,123-138.
  • 8Fong MC,Chen KC, Leu HB, et al. Coronary revascularization in a patient with immune thrombocytopenic purpura. J Chin Med Assoc ,2006,69:436-438.
  • 9Araki T, Tofuku Y. An elderly case of idiopathic thrombocytopenic purpura associated with acute myocardial infarction. Nippon Ronen lgakkai Zasshi, 1999,36:742-746.
  • 10Fruchter O ,Blich M, Jacob C. Fatal acute myocardial infarction during severe thrombocytopenic purpura. Am J Med Sci, 2002, 323:279-280.

共引文献6

同被引文献67

  • 1RodeglnemF, Stasi R, Gemsheimer T, et al. Standardizatianof terminol- ogy ,definitions and outcome eriteria in immune thrombocytopenie pur- puraof adults and children : report froman international working group [J]. Blood,2009,113( 11 ) :2386-2396.
  • 2Pierrot-deseilligny Despujol C, Michel M, Khellaf M, et al. Antiphos- pholipid antibodies in adults with immune thrombocytopenic purpura[ J]. Br J Haemato1,2008,142:638-643.
  • 3Syed WY, Cezar I, Jaya DB, et al. Antiplatelet Therapy and Percutane- ous Coronary Intervention in Patients with Acute Coronary Syndrome and Thrombocytopenia [ J ]. Tex Heart lnst J,2010,37 (3) :336-340.
  • 4Yadav M ,Genereux P,Kirtane AJ ,et al. TCT-244 Baseline Thrombocy- topenia:A Strong Predictor Of One-Year Adverse Ischemic Events In Patients With ACS Undergoing PCI:A Pooled analysis From ACUITY And HORIZONS-AMI Trials [ J ]. J Am Coll Cardiol, 2013,62 ( 18 ) : B80.
  • 5Daniel BS,Peter JP, Stephen K, et al. Outcomes after PCI in patients with thrombocytopenia[ J]. J Am CoU Cardio1,2013,61 (10) :E718.
  • 6Torbey E, Yacoub H ; Cord DM, et al. Two Cases and Review of the Literature:Primary Percutaneous Angiography and Antiplatelet Man- agement in Patients with Immune Thrombocytopenic Purpura [ J ]. IS- RN Hernato1,2013 ,2013 : 174659.
  • 7Ghassan Z. Immune thrombocytopenic Purpura and myocardial infarc- tion : a dilemma of management [ J ]. IMAJ, 2013,15:775-776.
  • 8Bora D, Meltem A, Fadime B, et al. Coronary intervention for acute coronary syndrome in a 51 -year-old man with immune thrombocytope- nic purpura: a case report[ J]. J Med Case Rep ,2014 ,8 :214-218.
  • 9Sarkiss MS, Yusuf W, Warneke CL, et al. Impact of Aspirin Therapy in Cancer Patients With Thrombocytopenia and Acute Coronary Syn- dromes[ J]. Cancer,2007,109:621-627.
  • 10Hefer D, Jaloudi M. Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients : a case report and discussion of the relevant literature [ J ]. Ann Hematol,2005,84 ( 6 ) :411-415.

引证文献8

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部